KPTI KARYOPHARM THERAPEUTICS
Health Care · Russell 2000
Next earnings: Thu 12 Nov 2026 · estimated
What 10 analyst firms say about KARYOPHARM THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
7 rated views · 10 analyst/firm records · 10 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 2 reports on KPTI from 2 analyst firms in the last 90 days (10 firms in the past year).
Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Baird | Michael Ulz | Hold | 31 Jul 2026 | 3.00 USD |
| Cantor Fitzgerald | Yanni Souroutzidis | Buy | 9 Jun 2026 | — |
| Goldman Sachs | Unnamed analyst | — | 17 Dec 2025 | 12.00 USD |
| H.C. Wainwright | Robert Burns | ConflictConflicting reports · excluded | 31 Jul 2026 | 3.00 USD |
| Jefferies | Maury Raycroft | Buy | 31 Jul 2026 | 11.00 USD |
| Piper Sandler | Edward Tenthoff | Buy | 31 Jul 2026 | 7.00 USD |
| RBC Capital Markets | Brian Abrahams | Buy | 21 Jul 2026 | Conflicting reports · excluded |
| Rodman & Renshaw | Michael G King | Buy | 31 Jul 2026 | 28.00 USD · 10 Mar 2026 |
| Weiss Ratings | Unnamed analyst | — | 24 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 08:11 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.